Back to Peptide Library
Reproductive Signaling

Kisspeptin-10

Active 10-Amino-Acid Fragment • KISS1R / GPR54 Agonist

Kisspeptin-10 is the active C-terminal fragment of kisspeptin. It stimulates hypothalamic GnRH signaling and can acutely increase LH, FSH, and downstream sex-hormone activity in responsive individuals.

Route
SubQ
Compound type
KISS1R agonist
Regulatory status
Not FDA approved
Last reviewed
At a glance

Kisspeptin-10 Quick Reference

Community dose
100–200mcg
SubQ every other day
Community cycle
4–8 weeks
Track baseline and follow-up labs
Research target
KISS1R
Upstream GnRH and gonadotropin signaling
Route
SubQ Injection
Community protocol; distinct from study infusions
Overview

What Is Kisspeptin-10?

Kisspeptin-10 is a synthetic version of the active 10-amino-acid C-terminal fragment of kisspeptin-54. It retains activity at the kisspeptin receptor, KISS1R (also called GPR54).

Hypothalamic kisspeptin neurons help regulate the hypothalamic-pituitary-gonadal axis. KISS1R activation stimulates GnRH neurons; GnRH then signals the pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In men, LH supports testicular testosterone production, while FSH contributes to Sertoli-cell function and sperm production.

This upstream action differs from hCG, which acts at the testicular LH receptor, and testosterone replacement, which supplies hormone externally and usually suppresses endogenous gonadotropins. It also differs from enclomiphene's estrogen-receptor blockade. Human studies confirm acute hormone signaling, but repeated-cycle, fertility, and long-term outcomes remain uncertain.

Mechanism

Kisspeptin-10 Mechanism of Action

KISS1R activation

Kisspeptin-10 binds its receptor on GnRH-regulating neurons in the hypothalamus.

GnRH release

The hypothalamus sends a gonadotropin-releasing hormone signal to the pituitary.

LH and FSH

The pituitary releases LH and FSH; their response depends on the rest of the reproductive axis.

Downstream hormones

In responsive men, this can increase testicular testosterone signaling without directly replacing testosterone.

Research findings

Kisspeptin-10 Benefits

Human studies show acute signaling and sexual-processing effects; durable testosterone or fertility benefits have not been established.

Endogenous Testosterone Signaling

Acute LH increases can be followed by testosterone changes in some men; this is not equivalent to a proven long-term testosterone protocol.

Fertility Pathway

LH and FSH engage pathways relevant to testicular function and spermatogenesis, but improved sperm count or fertility is not guaranteed.

Sexual Desire Research

A randomized study in men with low sexual desire reported changes in sexual-processing activity and arousal measures versus placebo.

Axis Preservation

Because it does not supply testosterone directly, kisspeptin differs from replacement therapy; repeated-cycle recovery is still unproven.

Protocol planning

Kisspeptin-10 Dosing Protocol

The SubQ range is community and clinic-derived, not a controlled-trial protocol. Published IV and intranasal research doses do not translate directly to this route.

Members Access Only

Sign in or create a free account to view this content.

Preparation

Kisspeptin-10 Reconstitution

Example concentration

10mg vial + 3mL bacteriostatic water

Result≈3.33mg/mL

Reconstitution steps

1
Prepare

Wash your hands, clean the work surface, and wipe both vial stoppers with alcohol. Allow them to dry.

2
Add diluent slowly

Use a new sterile syringe and needle to direct the selected volume of compatible diluent down the inside wall of the vial.

3
Dissolve gently

Swirl or roll the vial until the contents dissolve; do not shake.

4
Store

Store refrigerated at 2–8°C (36–46°F) and protected from light when the product instructions support this. Record the reconstitution date in your research journal.

N=1 reports

Kisspeptin-10 Community Experience

Community reports are personal observations and do not establish a reliable hormone or fertility outcome.

Positive Reports

  • Some users describe modest improvements in libido, energy, or well-being.
  • People concerned about testosterone-replacement suppression are interested in the upstream mechanism.
  • Lab tracking can reveal whether LH, FSH, and testosterone actually respond.

Negative & Mixed Reports

  • Effects can be subtle or absent despite a plausible mechanism.
  • Injection-site irritation, headache, flushing, fatigue, or nausea are reported.
  • Anecdotal hormone changes may not persist with repeated exposure.
Stacking & synergy

Kisspeptin-10 Stacking & Synergy

These pairings target different points in hormone or sexual-response pathways. No combination below has an established community dosing protocol.

Kisspeptin + Enclomiphene

Both may increase gonadotropin signaling by different mechanisms. Combined response and feedback effects need lab monitoring.

Kisspeptin + hCG

Kisspeptin acts upstream through GnRH and pituitary LH/FSH; hCG acts at the testicular LH receptor. Combining them can obscure which signal changed results.

Kisspeptin + CJC-1295 No DAC / Ipamorelin

The former addresses reproductive signaling; the latter is used for growth-hormone signaling. Their combined outcomes have not been established.

Kisspeptin + PT-141

Kisspeptin targets the reproductive hormone axis; PT-141 acts through melanocortin signaling. Their combined sexual effects have not been established.

Safety notes

Kisspeptin-10 Side Effects & Safety

Kisspeptin-10 is not FDA approved. Short human studies establish acute biological activity, but do not validate long-term community SubQ use.

Reported Effects

  • Injection-site irritation, headache, flushing, fatigue, or nausea.
  • Hormone changes may alter mood, libido, or estrogen-related symptoms.

Monitoring Concerns

  • Responses vary with pituitary and gonadal function; a weak response warrants evaluation rather than automatic dose escalation.
  • Repeated or continuous stimulation may not behave like an acute research dose; long-term safety is unknown.

Kisspeptin-10 Precautions

Avoid or Discuss With a Clinician If
  • Known hypersensitivity to kisspeptin or formulation ingredients.
  • Pregnancy, breastfeeding, or active hormone-sensitive cancer.
  • An undiagnosed reproductive or pituitary disorder.
Use Caution With
  • Concurrent hormone-active medications or fertility treatment.
  • No baseline or follow-up LH, FSH, testosterone, and estradiol measurements.
  • An unverified research product with uncertain identity or sterility.
Kisspeptin-10 is not FDA approved, and no standardized long-term SubQ regimen exists.
Final verdict

Peptide Protocols Verdict on Kisspeptin-10

Not medical advice. This editorial is our own opinion piece based off the experience of our own lab rats.
Our opinionated opinion

We like kisspeptin for the possibility of supporting natural testosterone and fertility signaling. It works upstream of LH and FSH, so it feels like a more measured option to explore than moving straight to testosterone replacement when preserving the HPG axis matters. We also expect more modest results than stronger hormonal interventions.

We have seen people report subtle, sustainable benefits and others who barely notice a difference. For us, bloodwork is essential: establish a baseline, then check whether LH, FSH, testosterone, and estradiol actually move. We give it a B because the acute human signal is real, while the community schedule and lasting outcomes still need better evidence.